Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, April 14, 2025 /PRNewswire/ -- Equity Insider News Commentary - Routine medical ...

Prostate cancer has distinct genetic properties in different groups of men that can be targeted to improve patient outcomes, UVA Cancer Center researchers have discovered.

"I am thrilled to join the Prostate Cancer Foundation, an organization making a profound impact on the prostate cancer community," said Dr. Koo. "Prostate cancer is a devastating disease ...

The University of Queensland will play a key role in a national effort to revolutionize treatment for men with prostate cancer.

Professor Ros Eeles, from the Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, said: "With this test, it could be possible to turn the tide on prostate cancer.

“The funding from Perpetual Guardian Foundation also supports verifying the approach towards it becoming the general standard for prostate cancer diagnosis in New Zealand. “New Zealand was 10 ...

The awards acknowledge outstanding contributions to urological research, specifically in pediatrics and prostate cancer. They recognize the accomplishments of previous Urology Care Foundation grant ...

The Prostate Cancer Foundation (PCF) today announced the appointment of Phillip Koo, M.D., as chief medical officer. Dr. Koo will lead PCF’s patient navigation programs, help increase ...

the Prostate Cancer Foundation recommends prostate-specific antigen testing beginning at age 40. Prostate cancer is the second-leading cause of cancer death in American men, behind only lung cancer.

At Keck Medicine of USC, part of a large nationwide study, researchers are trying to find out if steam can treat prostate cancer safely and effectively. Prostate cancer is common, but treatment ...